Aimmune Therapeutics Inc (AIMT) Annual Balance Sheets

Annual · GAAP · USD millions
Access AIMT quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Aimmune Therapeutics Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Assets
Cash & cash equivalent79.88
Available-for-sale Securities, Debt Securities, Current MA63.63
Cash & Short-term Investments142.00
Prepaid Expense And Other Assets Current5.56
Total Current Assets149.08
Equipment/Property/Plant Net28.60
Long-term investments14.66
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset11.51
Prepaid Expense And Other Assets Noncurrent0.52
Total Assets204.37
Liabilities
Accounts Payable, Current AC13.88
Accrued Liabilities, Current AC31.29
Other Liabilities, Current0.02
Total Current Liabilities47.45
Long-term debt41.03
Total Long-term Debt41.03
Other liabilities, Noncurrent1.35
Operating Lease Liability Current2.26
Operating Lease Liability Noncurrent10.52
Total Liabilities100.35
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock828.62
Retained Earnings / Accumulated Deficit-724.68
Other Equity0.08
Common Stockholder's Equity104.02
Total Stockholder's Equity104.02
Liabilities & Stockholder's Equity204.37
4 historic quarters locked

Sign in to unlock the full Aimmune Therapeutics Inc balance sheet history.

About AIMT Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License